The tumor growth in vivo requires new vessels to provide nutrition and oxygen, thus, the tumor cells recruit proangiogenic cytokines to induce tumor angiogenesis, and VEGF, mainly secreted from tumors, has been demonstrated to be the critical proangiogenic stimulator in neovascularization during the process of tumor development [6–10]. The gene discussed is VEGFA; the disease is neoplasm.